Concepedia

Publication | Closed Access

Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin

DOI

154

Citations

26

References

2011

Year

Hiroyuki Suzuki, Masaru Terai, Hiromichi Hamada, Takafumi Honda, Tomohiro Suenaga, Takashi Takeuchi, Norishige Yoshikawa, Shoichi Shibuta, Masakazu Miyawaki, Ko Oishi,
The Pediatric Infectious Disease Journal

Abstract

CyA treatment is considered safe and well tolerated, and a promising option for patients with refractory KD. Further investigations will be needed to clarify optimal dose, safety, and timing of CyA treatment.

References

YearCitations

Page 1